Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
Status:
COMPLETED
Trial end date:
2023-11-15
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the onset of analgesia following administration of a single oral dose of PF614 (50 mg or 100 mg) or placebo in healthy male subjects in an experimental pain model (cold pressor test \[CPT\]).